G Dow

502 total citations
7 papers, 367 citations indexed

About

G Dow is a scholar working on Infectious Diseases, Surgery and Molecular Biology. According to data from OpenAlex, G Dow has authored 7 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Infectious Diseases, 3 papers in Surgery and 2 papers in Molecular Biology. Recurrent topics in G Dow's work include Diabetic Foot Ulcer Assessment and Management (2 papers), Escherichia coli research studies (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). G Dow is often cited by papers focused on Diabetic Foot Ulcer Assessment and Management (2 papers), Escherichia coli research studies (2 papers) and Viral gastroenteritis research and epidemiology (1 paper). G Dow collaborates with scholars based in United States, Canada and United Kingdom. G Dow's co-authors include R. Gary Sibbald, Rezika Mohammed, David M. Davidson, David A. Johnson, Jennifer Peppe, Stacey L. Simon, Gary Garber, Thomas Louie, Joseph F. John and K.H. Weiss and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Bacteriology and Canadian Journal of Infectious Diseases and Medical Microbiology.

In The Last Decade

G Dow

7 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G Dow United States 5 165 148 148 93 84 7 367
Haidy G. Rivero United States 7 51 0.3× 146 1.0× 194 1.3× 78 0.8× 29 0.3× 8 459
A. J. van Griethuysen Netherlands 3 105 0.6× 137 0.9× 56 0.4× 229 2.5× 43 0.5× 4 372
Asima Banu India 8 83 0.5× 100 0.7× 46 0.3× 24 0.3× 88 1.0× 21 319
Aobuliaximu Yakupu China 7 26 0.2× 114 0.8× 99 0.7× 27 0.3× 22 0.3× 11 268
Marilena Chinali Komesu Brazil 12 139 0.8× 43 0.3× 90 0.6× 41 0.4× 21 0.3× 34 335
Benjamin Kressmann Switzerland 13 31 0.2× 316 2.1× 27 0.2× 147 1.6× 349 4.2× 19 483
José Neves Portugal 7 48 0.3× 131 0.9× 23 0.2× 39 0.4× 159 1.9× 21 250
WALTER E. SWITZER United States 9 16 0.1× 212 1.4× 196 1.3× 103 1.1× 12 0.1× 15 408
Allie Clinton Smith United States 8 28 0.2× 113 0.8× 44 0.3× 44 0.5× 47 0.6× 13 313
Caroline Whately‐Smith United Kingdom 9 85 0.5× 25 0.2× 17 0.1× 72 0.8× 117 1.4× 11 424

Countries citing papers authored by G Dow

Since Specialization
Citations

This map shows the geographic impact of G Dow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Dow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Dow more than expected).

Fields of papers citing papers by G Dow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Dow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Dow. The network helps show where G Dow may publish in the future.

Co-authorship network of co-authors of G Dow

This figure shows the co-authorship network connecting the top 25 collaborators of G Dow. A scholar is included among the top collaborators of G Dow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Dow. G Dow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
2.
3.
Shameer, Khader, G Dow, Benjamin S. Glicksberg, et al.. (2018). A Network-Biology Informed Computational Drug Repositioning Strategy to Target Disease Risk Trajectories and Comorbidities of Peripheral Artery Disease.. PubMed. 2017. 108–117. 6 indexed citations
4.
Dow, G, et al.. (2010). Ceftobiprole: First Reported Experience in Osteomyelitis. Canadian Journal of Infectious Diseases and Medical Microbiology. 21(3). 138–140. 8 indexed citations
5.
Louie, Thomas, Jennifer Peppe, David A. Johnson, et al.. (2006). Tolevamer, a Novel Nonantibiotic Polymer, Compared with Vancomycin in the Treatment of Mild to Moderately Severe Clostridium difficile-Associated Diarrhea. Clinical Infectious Diseases. 43(4). 411–420. 154 indexed citations
6.
Dow, G, et al.. (1999). Infection in chronic wounds: controversies in diagnosis and treatment.. PubMed. 45(8). 23–7, 29. 188 indexed citations
7.
Nicolle, LE, et al.. (1998). Infectious Diseases on a General Internal Medicine Clinical Teaching Unit. Canadian Journal of Infectious Diseases and Medical Microbiology. 10(1). 33–38. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Haidy G. Rivero Breakdown of academic impact, for papers by A. J. van Griethuysen Breakdown of academic impact, for papers by Asima Banu Breakdown of academic impact, for papers by Aobuliaximu Yakupu Breakdown of academic impact, for papers by Marilena Chinali Komesu Breakdown of academic impact, for papers by Benjamin Kressmann Breakdown of academic impact, for papers by José Neves Breakdown of academic impact, for papers by WALTER E. SWITZER Breakdown of academic impact, for papers by Allie Clinton Smith Breakdown of academic impact, for papers by Caroline Whately‐Smith
Rankless by CCL
2026